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SUMMARY · Pseudomonas (P.) aeruginosa produces a number of exoenzymes, which have been
implicated as virulence factors in infections caused by this organism. One of these exoenzymes is
phospholipase C or heat labile hemolysin (HE) or P. aeruginosa. The aim of the study was to estab-
lish differences in HE production of 100 P. aeruginosa strains in dependence of their antigenic struc-
ture and type of specimens from which they were isolated. Isolates were serotyped by agglutination
with commercial antisera according to the International Antigenic Typing System. A microtiter HE
assay was used to quantitate the hemolytic activity of the strains investigated. The most commonly
detected O-serogroup was O11, found in 34% of strains, followed by O6 (16%), O3 (9%), O4 (8%),
O2 (7%) and O1 (6%) serogroups. Serogrups O7, O10, O13, O14, O15 and O17 were not detected.
Serogroup O11 was found in 11 out of 16 strains isolated from bronchial secretion, and in 2 of 15
strains isolated from urine (p<0.01). HE production was detected in 88% of all isolates. The O1, O2,
O3 and O16 strains mostly produced a large quantity of HE, while the epidemic O11 strains pro-
duced a small amount of HE. Urine and pharyngeal isolates produced the highest levels of HE.
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ity. Despite antibiotics, the lethality directly or indirectly
related to this bacterium is one of the highest among the
nosocomial pathogens4.
The virulence of P. aeruginosa is multifactorial and is
the product of many interacting variables, involving both
the bacterium and the host. Damage to the host tissue may
occur directly through the action of bacterial products or
indirectly through the induction of an exaggerated host
response to these products. In addition to cell-associated
factors, P. aeruginosa liberates a number of exoenzymes,
including exotoxin A, proteolytic enzymes, phospholipase
C, and exoenzyme S, each of which has been implicated
as a pathogenic determinant in infections caused by this
organism1,3. Exotoxin A has been shown to be a patho-
genic determinant in experimental infections of the eye
and burn wounds, and in chronic lung infections caused
by P. aeruginosa5,6. The activity of proteases, such as alka-
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Introduction
Pseudomonas (P.) aeruginosa has emerged as an impor-
tant nosocomial pathogen during the past three decades.
It causes between 10% and 20% of infections in most hos-
pitals1. Moreover, the incidence and relative frequency of
hospital-acquired P. aeruginosa infection have increased
during the last decades. This is partly due to the increased
number of patients particularly prone to such infections:
immunocompromised patients, and patients with malig-
nancy, cystic fibrosis, burns or traumatic wounds2,3. Infec-
tion with P. aeruginosa is associated with severe morbid-
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line protease and elastase, has been well established in most
P. aeruginosa strains1,7. Recent studies have shown that
elastase contributes to the pathogenesis in acute and chronic
lung infections8,9, and together with exotoxin A may con-
tribute to the development of fatal septicemia10. Exoen-
zyme S, an adenosine-disphosphate-ribosyl (ADPR) trans-
ferase enzyme, like exotoxin A, is an important virulence
factor in burn infections caused by P. aeruginosa11.
The role of phospholipase C in human infections has
not yet been fully clarified. Phospholipase C is a lecithi-
nase, which liberates phosphorylcholine from lecithin, and
is also known as a heat labile hemolysin12. Together with
a heat stabile glycolipid, it acts synergistically to break
down lipids and lecithin. Like Pseudomonas proteases,
hemolysins can contribute to tissue invasion through their
necrotizing effects. It has also been suggested that phos-
pholipase C contributes to the pathogenesis of Pseudomo-
nas pneumonia through the degradation of lung surfac-
tants12.
The purpose of the present study was to determine the
in vitro production of hemolysin among phenotypically
different P. aeruginosa strains isolated from a variety of
clinical isolation sites.
Material and Methods
Bacterial strains: A total of 100 P. aeruginosa isolates
from different specimens (urine, bronchial secretion ob-
tained by fiberoptic bronchoscopy, endotracheal aspirate,
sputum, ear and throat swabs, pus and wound aspirate)
were collected from the Department of Microbiology,
Institute of Public Health at Osijek, Croatia, from Feb-
ruary 1 to June 17, 1998. All patients had symptoms and
signs of underlying infection of the system involved, and
cultures were taken during standard diagnostic proce-
dures.
Bacteria were characterized as P. aeruginosa according
to their biochemical characteristics established by means of
API 20 NE System (API, Analytab Products, Plainview,
NY, USA). Multiple isolates from the same patient were
excluded from the study. Strains were stored in deep-agar
tubes at +4 °C (1.5% nutrient agar, Difco Lab., Detroit, MI,
USA), and subcultured by passaging on trypticase soy agar
(TSA, Difco Lab., USA) before use.
Serotyping: O-serogroups of the P. aeruginosa strains
were determined by slide agglutination using commer-
cially available antisera ( Diagnostic Antisera, Institute of
Immunology, Zagreb, Croatia) according to the Interna-
tional Antigenic Typing System.
Measurement of hemolytic activity: A modified micro-
titer hemolysin assay described previously by O’Hanley et
al. was used to quantitate the hemolytic activity of bacte-
ria13. In short, a single bacterial colony on trypticase soy
agar for each strain was inoculated into tubes containing
Luria broth ( Difco Lab., Detroit, USA ). After incuba-
tion for 5 h at 37 °C using a shaker (Lucham Ltd.), one
milliliter of this culture served as inoculum for 60 ml of
medium contained in cotton-stoppered Erlenmeyer flask
incubated at 37 °C on a shaker for 24 h. Bacteria were
removed from culture supernatants by centrifugation (1
200 xg). The supernatant was filtered through 0.4-µm
pore-size membranes (Millex-HA Filter, Millipore,
Molsheim, France) and serially diluted twofold in phos-
phate-buffered saline (0.067 M potassium phosphate
buffer, pH 6.8, with 0.077 M NaCl). Hemolytic activity
was tested by combining equal volumes (50 µl each) of an
erythrocyte suspension in assay buffer (human blood type
0 erythrocytes, final concentration 2%) and culture super-
natant in microtiter plates (Falcon 3077, Becton Dickin-
son Labware, New Jersey, USA). Plates were incubated at
37 °C for 2 h, and the hemolytic titers were expressed as
the reciprocal of the highest dilution at which any hemoly-
sis was observed.
Statistical analysis: The χ2-test was used to test the sig-
nificance of differences. A probability of 0.01 was consid-
ered significant.
Results
The distribution of the P. aeruginosa serotypes among
100 studied isolates is summarized in Tables 1, 2 and 4.
Somatic type O11 was most frequently identified (34%),
followed by O6 (16%). Other somatic types accounted for
less than 10.0% each, and four strains failed to aggluti-
nate any somatic antiserum (non-typable strains, NT).
Serogroups O7, O10, O13, O14, O15, and O17 were not
detected among investigated strains.
Table 1 shows the distribution of most frequent sero-
types among isolates from various clinical sources. Twelve
strains were isolated from endotracheal aspirates, 16 from
bronchial secretion obtained by fiberoptic bronchoscopy,
and seven from sputum. Ten strains were isolated from
pharyngeal swabs, nine from ear swabs, 17 from wound
swabs, 15 from urine and seven from different materials
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Table 1. Distribution of most frequent serogroups among isolates from various clinical materials
Specimen Serogroup
O11a O6  O3   O4 O2 O1 Others   Total (N, %)
Endotracheal aspirate 3 3 2 0 0   0   4 12
Bronchial secretion 11 1 1 0 0   0   3 16
Sputum 2 1 2 0 0   0   2   7
Pharyngeal swab 0 2 3 2 2   0   1 10
Ear swab 1 3 0 1 1   3   0   9
Wound aspirate 8 1 1 2 3   0   2 17
Urine 2 3 0 1 1   3   5 15
Biomaterialsb 4 1 0 1 0   0   1   7
Others 3 1 0 1 0   0   2   7
Total (N, %) 34 16 9 8 7   6 20 100
a Differences statistically significant (χ2=17.11; p<0.01)
b Cultivation of bacteria from different biomaterials (catheters, tubes, etc.) was performed by use of standardized microbiological
techniques
(pus, exudates, etc.). Seven strains were cultivated from
different biomaterials (chateters, tubes, etc.) during the
standard diagnostic procedure. A statistically significant
difference was observed in the distribution of strains in
which O11 serogroup was detected (χ2=17.11, DF=4,
p<0.01). The difference occurred due to a higher than
expected frequency of O11 serotype among strains iso-
lated from bronchial secretion, wound aspirates and bio-
material cultures, and a lower than expected frequency of
O11 strains among other respiratory tract isolates and
isolates from urine. Serogroup O6 was most frequently
detected among strains isolated from urine, ear swabs, and
endotracheal aspirates. The O1, O2, O3 and O4 serotypes
were mostly detected among isolates from ear and pha-
ryngeal swabs and wound aspirates.
Table 2 shows the distribution of most frequent sero-
groups in P. aeruginosa isolates depending on strain origin.
Twenty-six strains were recovered from outpatients,
whereas 74 strains were recovered from patients at differ-
ent clinical wards of the Osijek University Hospital. The
difference in the distribution of O11 serogroup was statis-
tically significant. The O11 strains were mostly isolated
from patients at the pulmonology and surgery wards, and
from intensive care unit patients (χ2=15.84, DF=5, p<0.01).
The O6 serotype was rarely detected among strains isolated
from these clinical wards, but was frequently detected
among strains from the pediatric ward. Antigenic variability
was greatest among the strains isolated from outpatients.
The ability of hemolysin (HE) production of investi-
gated strains was compared by hemolysis titer (Table 3).
Hemolysin production was recorded in 88% of all isolates,
but 39% of strains produced low amounts of HE. The
differences between strains isolated from different mate-
rials were statistically significant (χ2=25.02, DF=6,
P<0.01). Strains isolated from bronchial secretion mostly
produced low amounts of HE (hemolysis titer 2-4) or did
not produce HE at all, while strains isolated from urine,
pharyngeal and ear swabs mostly produced high amounts
of HE (hemolysis titer ≥8). The highest HE production
was detected in a strain isolated from urine (hemolysis ti-
ter 128).
As regards serogroup specificity, it was observed that
epidemic O11 strains mostly produced low amounts of HE,
while O1, O12 and O16 strains, and O2, O3 and O4 strains
mostly produced high HE amounts (Table 4). The observed
differences were statistically significant (χ2 = 25.35, DF=4,
p<0.01 after the fusion of “0” and “2-4” columns).
Discussion
In this study, the most frequently detected serogroups
were O11 (34%) and O6 (16%), followed by O3 (9%), O4
(8%), O2 (7%), and O1 (6%) serogroups. Limitations to
serotyping include poor discriminating power, polyagglu-
tination for some strains, failure of serotyping in lipopoly-
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Table 2. Distribution of most frequent serogroups in Pseudomonas aeruginosa isolates according to strain origin
Strain origin Serogroup
O11b O6c  O3   O4 O2 O1 012 016    Others     Total
(N, %)
Outpatients 2 5 2 2 4 6 1 0 4 26
OUH - ICUa 6 0 1 1 0 0 1 2 1 12
OUH - Surgery 6 2 1 3 3 0 0 0 1 16
OUH - Pulmonology 11 1 2 0 0 0 0 0 5 19
OUH - Pediatrics 3 5 2 2 0 0 0 2 0 14
Others 6 3 1 0 0 0 2 0 1 13
Total (N, %) 34 16 9 8 7 6 4 4 12 100
a OUH=Osijek University Hospital; ICU=intensive care unit
b Differences statistically significant (χ2=15.84; p<0.01)
c Differences statistically significant (χ2=7.17; p<0.01)
Table 3. Production of hemolysin of Pseudomonas aeruginosa
strains isolated from different clinical specimens
Titer of hemolysisa
Specimen Total
0      2-4         ≥8        (N, %)
Endotracheal aspirate 2 6 4 12
Bronchial secretion 3 10 3 16
Sputum 2 3 2 7
Pharyngeal swab 0 1 9 10
Ear swab 0 3 6 9
Wound aspirate 4 5 8 17
Urine 0 2 13 15
Biomaterialsb 1 4 2 7
Others 0 5 2 7
Total (N, %) 12 39 49 100
a Differences statistically significant (χ2=25.02; p<0.01)
b Cultivation of bacteria from different biomaterials (catheters, tubes,
etc.) was performed by use of standardized microbiological tech-
niques
Table 4. Comparison of serogroup specificity and hemolysin
production ability of investigated strains
Titer of hemolysisb
Serogroup  Total
        0           2-4       ≥8       (N, %)
O11 3 25 6 34
O6 4 2 10 16
O3 2 0 7 9
O4 2 2 4 8
O2 0 2 5 7
O1 0 1 5 6
O16 0 1 3 4
O12 0 0 4 4
O5 0 2 1 3
NTa 1 3 0 4
Others 0 1 4 5
Total (N, %) 12 39 49 100
a NT=non-typable strain
b Differences statistically significant (χ2=25.35; p<0.01)
saccharide-defective strains, and autoagglutination in cys-
tic fibrosis strains3,14. However, serotyping of P. aeruginosa
remains useful and epidemiologically significant3. It has
been shown that the most frequent serotypes involved in
nosocomial infections are O6, O11, O1 and O3, and that
serotype O12 is characterized by an exceptional multire-
sistance pattern15-20. Serogroup O11 was recognized as the
major cause of epidemics both in the USA and Eu-
rope17,18. Importance of serogroup O11 in hospital envi-
ronments was also confirmed in the present study, but
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serogroup O12 was detected only four times, and none of
these isolates were multiresistant (data not presented). As
the serotype determination and antibiotic susceptibility
pattern are insufficient for precise characterization of epi-
demiological circulation of P. aeruginosa strains, further
studies are needed to establish whether epidemic O11 and
O6 strains consist of homogeneous genotypes, or whether
subtypes or clones could be identified by use of genotyping
methods.
Evidence has also been reported indicating the preva-
lence of P. aeruginosa serotypes O4, O6, O11 and O12 in
hospital-acquired urinary tract infections (UTIs)18,21. In
addition, by combining multiple typing techniques, con-
sistent epidemiological correlation has been established,
leading to the hypothesis of a possible clonal origin for
some uropathogenic strains belonging to serotypes O4 and
O1219. It appears, therefore, that as with uropathogenic
Escherichia (E.) coli, only a few serogroups of P. aeruginosa
cause a major proportion of UTIs. In the present study,
out of 15 strains isolated from urine of patients with es-
tablished UTI (≥105 bacteria/ml urine), serogroups O12,
O6 and O1 were detected in three strains each, O11
serogroup in two, and O2, O4, O5 and O16 in one P. ae-
ruginosa strain. Comparing with other clinical specimens,
strains isolated from urine produced the highest levels of
hemolysin. This enzyme was also produced at very high
levels in 100% of P. aeruginosa strains from UTIs studied
by Woods et al.22, but not in all strains studied by Visca
et al.21, who observed a high degree of heterogeneity
among isolates. In this study, elevated levels of hemolysin
and other exoenzymes were characteristic of serotypes of
minor numerical importance, while low levels of hemol-
ysin were produced by strains belonging to the predomi-
nant serotypes21. Similarly, we noticed that epidemic O11
strains produced low levels of hemolysin, and strains in
which O1, O2, O3, O12 and O16 serotypes were detected
mostly produced high levels of hemolysin.
The importance of hemolysin production in P. aerugi-
nosa pathogenesis is not clear. It has been suggested that
hemolysin plays a role in the colonization of mucous
membranes, implicating a local rather than systemic role
for this enzyme in P. aeruginosa pathogenesis22,23. Saiman
et al.24 studied the adherence ability of P. aeruginosa strains
to the respiratory tract epithelial cells and showed that
phospholipase C and proteases increased the adherence
ability of the bacteria by modification of the glycoco-
njugates on the surface of epithelial cells. On the contrary,
Woods et al.25 have suggested a systemic role of this en-
zyme, based on the results of the neutropenic mouse model
of infection. They observed that the presence of high lev-
els of exoenzyme S in association with phospholipase C
correlated with a low number of bacteria required to elicit
the 50% lethal dose25.
It is possible that the low levels of hemolysin produc-
tion observed in the present study in epidemic O11 strains
isolated from bronchial secretion of patients hospitalized
on the pulmonology ward were the result of colonization
duration. Burke et al.26 showed the duration of coloniza-
tion to correlate with bacterial phenotype. They confirmed
that P. aeruginosa from chronically colonized patients
tended to be less motile, and produced lower levels of elas-
tase, protease, exotoxin A and hemolysin. Similarly,
Woods et al.27 observed a significant decrease in the lev-
els of endotoxin A, exoenzyme S and phospholipase C by
using a chronic pulmonary infection model.
Conclusions
1. The present study confirmed previous observations
of the epidemiological predominance of O11 serogroup.
Multiresistant O12 strains, also epidemic in Europe, were
not detected, and moreover, O12 serogroup was of minor
numerical importance.
2. The data presented indicate that the hemolysin lev-
els varied significantly, depending on the site of isolation
and serotype of the strain.
3. As in uropathogenic E. coli infections, hemolysin
production seems to be a virulence factor in P. aeruginosa
UTIs.
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SAÆETAK
RAZLIKE U ANTIGENOJ STRUKTURI I STVARANJU HEMOLIZINA ME–U SOJEVIMA
PSEUDOMONAS AERUGINOSA IZOLIRANIM IZ RAZLI»ITIH MATERIJALA
J. Vrane¹, I. BrkiÊ i M. Horonitz
Pseudomonas (P.) aeruginosa stvara brojne egzoenzime koji se dræe Ëiniteljima virulencije u infekcijama koje izaziva ovaj
mikroorganizam. Jedan od njih je fosfolipaza C ili termolabilni hemolizin P. aeruginosa. Svrha ovoga istraæivanja bila je utvrditi
razlike u stvaranju hemolizina 100 sojeva P. aeruginosa u ovisnosti o antigenoj strukturi soja i vrsti materijala iz kojega je soj
izoliran. Izolati su serotipizirani pomoÊu aglutinacije s komercijalnim antiserumima prema Internacionalnoj shemi za antigeno
tipiziranje. Metoda mikrotitracije rabljena je za kvantificiranje hemolitiËke aktivnosti istraæivanih sojeva. NajËe¹Êe je utvrðena
serogrupa O11, tj. u 34% sojeva, potom serogrupe O6 (16%), O3 (9%), O4 (8%), O2 (7%) i O1 (6%). Serogrupe O7, O10,
O13, O14, O15 i O17 nisu utvrðene meðu istraæivanim sojevima. Od 16 sojeva izoliranih iz sekreta bronha, serogrupa O11
naðena je u 11 sojeva, dok je od 15 sojeva izoliranih iz mokraÊe ista serogrupa naðena u dva soja (p<0,01). Stvaranje hemolizina
utvrðeno je u 88% svih izolata. Sojevi O1, O2, O3 i O16 stvarali su veliku koliËinu hemolizina, dok su epidemiËni sojevi O11
stvarali malu koliËinu hemolizina. Izolati iz mokraÊe i ædrijela stvarali su najvi¹e hemolizina.
KljuËne rijeËi: Pseudomonas aeruginosa, patogeniËnost; Pseudomonas aeruginosa, klasifikacija; Hemolizini
